Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Shares Outstanding (Weighted Average): 2013-2024

Historic Shares Outstanding (Weighted Average) for MediWound (MDWD) over the last 12 years, with Dec 2024 value amounting to $10.5 million.

  • MediWound's Shares Outstanding (Weighted Average) rose 17.20% to $10.9 million in Q3 2025 from the same period last year, while for Jun 2025 it was $10.8 million, marking a year-over-year increase of 16.94%. This contributed to the annual value of $10.5 million for FY2024, which is 14.01% up from last year.
  • As of FY2024, MediWound's Shares Outstanding (Weighted Average) stood at $10.5 million, which was up 14.01% from $9.2 million recorded in FY2023.
  • MediWound's 5-year Shares Outstanding (Weighted Average) high stood at $10.5 million for FY2024, and its period low was $3.9 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $9.2 million (2023), whereas its average is $8.5 million.
  • Data for MediWound's Shares Outstanding (Weighted Average) shows a peak YoY surged of 58.43% (in 2023) over the last 5 years.
  • MediWound's Shares Outstanding (Weighted Average) (Yearly) stood at $3.9 million in 2020, then increased by 0.16% to $3.9 million in 2021, then skyrocketed by 49.50% to $5.8 million in 2022, then surged by 58.43% to $9.2 million in 2023, then rose by 14.01% to $10.5 million in 2024.